Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer-Reference-Cited by-同舟云学术

Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer

Published:2020-03 Issue: Volume:141 Page:14-20
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cao Xiaowen,Ganti Apar Kishor^ORCID,Stinchcombe Thomas,Wong Melisa L.^ORCID,Ho James C.^ORCID,Shen Chen,Liu Yingzhou,Crawford Jeffery,Pang Herbert,Wang Xiaofei

Funder

NIH National Institute on Aging

NIH National Cancer Institute

Health and Medical Research Fund

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management;Crawford;Cancer,2004

2. A prospective investigation of chemotherapy induced neutropenia (CIN) and quality of life (QoL);Fortner;J. Clin. Oncol.,2005

3. Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials;Kristensen;Acta Oncol.,2018

4. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy;Lyman;Cancer,2011

5. The Statistical Evaluation of Medical Tests for Classification and Prediction;Pepe,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and risks of intravenous chemotherapy-induced severe neutropenia in solid cancers: a multicenter retrospective cohort study on real-life data;Supportive Care in Cancer;2024-09-13

2. Predictive value of TCM tongue characteristics for chemotherapy-induced myelosuppression in patients with lung cancer;Medicine;2024-04-12

3. Risk of bias assessments in individual participant data meta-analyses of test accuracy and prediction models: a review shows improvements are needed;Journal of Clinical Epidemiology;2024-01

4. The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study;Journal of Cancer;2024

5. Near-Infrared Spectroscopy with Supervised Machine Learning as a Screening Tool for Neutropenia;Journal of Personalized Medicine;2023-12-21